Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03139604
What this trial is testing

GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 439
Not applicableLooking for participantsNCT06279676
What this trial is testing

Improvement of Women's Health After Allogeneic Stem Cell Transplantation

Who this might be right for
GVHD, Chronic
Ciusss de L'Est de l'Île de Montréal 100
Not applicableStudy completedNCT03233659
What this trial is testing

Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell TransplantationGVHD
IRCCS Azienda Ospedaliero-Universitaria di Bologna 177
Testing effectiveness (Phase 2)Looking for participantsNCT06199427
What this trial is testing

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Who this might be right for
Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Testing effectiveness (Phase 2)Study completedNCT00346359
What this trial is testing

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Testing effectiveness (Phase 2)Study completedNCT02891395
What this trial is testing

Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host

Who this might be right for
Graft Versus Host Disease
University Hospital, Lille 65
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableEnded earlyNCT03102060
What this trial is testing

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseHematopoietic Cell Transplantation Recipient
Rutgers, The State University of New Jersey 7
Testing effectiveness (Phase 2)UnknownNCT01765660
What this trial is testing

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT00548717
What this trial is testing

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-vs-Host Disease
Dana-Farber Cancer Institute 15
Not applicableStudy completedNCT02398708
What this trial is testing

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Who this might be right for
Graft vs Host DiseaseGraft Versus Host DiseaseHematopoietic Stem Cell Transplantation+1 more
University of Florida 38
Post-approval studies (Phase 4)Looking for participantsNCT07029958
What this trial is testing

Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease

Who this might be right for
EBV-T/NK LPD
Beijing Children's Hospital 48
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Early research (Phase 1)Study completedNCT00079625
What this trial is testing

Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT04269850
What this trial is testing

Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

Who this might be right for
Intestinal GVHD
St. Petersburg State Pavlov Medical University 2
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT03983850
What this trial is testing

Optimizing PTCy Dose and Timing

Who this might be right for
Graft Versus Host DiseaseHematologic Neoplasms
National Cancer Institute (NCI) 105
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Next Page